ClinicalTrials.Veeva

Menu

Effect of Moderate Altitude (>1000 m.a.s.l.) on Sleep Examinations (Polysomnography).

T

Tsogyal Latshang

Status

Completed

Conditions

Healthy

Treatments

Diagnostic Test: Polysomnography

Study type

Interventional

Funder types

Other

Identifiers

NCT05826808
2023-00636

Details and patient eligibility

About

The purpose of this study is to investigate the effect of moderate altitude (>1000 m.a.s.l.) on sleep examinations (polysomnography).

Full description

Polysomnographies will be done for each participant for 2 consecutive nights at the sleep laboratory in Chur (CH; 600 m.a.s.l.) as well as for 2 consecutive nights at the participants home elevations (CH; >1000 m.a.s.l.). Between the measurements at those two different altitudes there will be a two-week washout period at >1000 m.a.s.l.. The sequence of altitude exposure will be randomized.

Enrollment

44 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy (no current medical condition or intake of regular medication, except negligible medical issues or accidents not interfering with the current health status or physical performance.)
  • Living above 1000 m.a.s.l. since at least 1 year
  • No overnight stay at altitudes <1000 m.a.s.l. in the previous 4 weeks
  • 18-70 years old
  • Body mass index 18,5-30 kg/m2
  • informed consent

Exclusion criteria

  • Active diseases or health related conditions that require treatment (sleep disorders (mainly sleep apnea), chronic rhinitis, cardiovascular and lung diseases)
  • Use of drugs that affect the respiratory center drive (sedatives, sleep inducing drugs, opioids), stimulants or illegal drugs
  • Regular consumption of recreational drugs (alcohol and nicotine included)

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

44 participants in 2 patient groups

A
Experimental group
Description:
Polysomnographies will be done first for 2 nights at the sleep laboratory in Chur (600 m.a.s.l.) and after a two-week washout period for 2 nights at the participants home elevations (\>1000 m.a.s.l.).
Treatment:
Diagnostic Test: Polysomnography
B
Experimental group
Description:
Polysomnographies will be done first for 2 nights at the participants home elevations (\>1000 m.a.s.l.). and after a two-week washout period for 2 nights at sleep laboratory in Chur (600 m.a.s.l.).
Treatment:
Diagnostic Test: Polysomnography

Trial contacts and locations

1

Loading...

Central trial contact

Nadja Deflorin; Tsogyal Latshang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems